Methadone + Ketamine for Pain Management in Liver Transplant
(RELIEF-LT Trial)
Trial Summary
What is the purpose of this trial?
The goal of this clinical trial is to learn if using methadone and ketamine during an adult deceased donor liver transplant can help decrease pain after surgery. The main questions it aims to answer are: * What impact does using methadone and ketamine during a deceased donor liver transplant have on pain after surgery? * Does the use of methadone and ketamine also have an impact on mental confusion (delirium) after surgery? Researchers will compare the use of methadone and ketamine to standard of care to see if the two drugs work to decrease pain and impact delirium after liver transplant. Participants will: * Receive either methadone and ketamine or standard of care during their deceased donor liver transplant. * Allow researchers to follow medical care throughout inpatient stay.
Research Team
Ryan Nazemian, MD, PhD
Principal Investigator
Lahey Hospital and Medical Center, Department of Anesthesiology, Perioperative and Pain Medicine
Eligibility Criteria
This trial is for adults undergoing a deceased donor liver transplant, aiming to reduce post-surgery pain. Participants will be observed throughout their hospital stay.Inclusion Criteria
Exclusion Criteria
Treatment Details
Interventions
- Ketamine (NMDA Receptor Antagonist)
- Methadone (Opioid)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Lahey Clinic
Lead Sponsor